1. NATCO PHARMA LTD
About Company: Since 1981, NATCO PHARMA LTD. is a well-established pharmaceutical company situated in Hyderabad city of India. With an initial investment of a modest sum of INR 3.3 Million, the company provides generics treatments to patients. Today, NATCO has seven manufacturing centers spread across the country with a dedicated researchers and safety labs that serving treatments to millions of patients across the world. Natco Pharma is reliable as it is treating patients from past several years and is trusted by many. NATCO is constantly ranked among the fastest growing pharmaceutical company.
Generic Hep C medicines by Natco Pharma
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Hepcinat Sofosbuvir 400 mg is rapidly absorbed and subject to extensive first-pass hepatic. It is a good generic alternatives & cost effective.
Manufacturing and Marketed by Natco Pharma Limited
Treatment genotype: Medicine used with other antiviral medicines to cure chronic (lasting a long time) hepatitis C (Hep C) with or without cirrhosis (compensated) in adults. In those with Hep C genotype (GT) 1 or 4 infections, Hepcinat Sofosbuvir is used in a composite with peginterferon alfa and ribavirin.
• Second Generation: (Sofosbuvir 400 mg + Ledipasvir 90 mg)
Generic Brand Name: Hepcinat LP tablets is a formulation combination of antiviral Sofosbuvir 400 mg and Ledipasvir 90 mg.
Manufacturing and Marketed by Natco Pharma Limited
Treatment genotype: Intake of Ledipasvir+Sofosbuvir can be done without ribavirin in most patients with genotype 1A, except those who are cirrhotic patients and treatment-experienced.
• Third Generation: (Sofosbuvir 400 mg + Velpatasvir 100 mg)
Generic Brand Name: Velpanat, is the generic version of Epclusa, which contains Velpatasvir 100 mg and Sofosbuvir 400 mg that helps to remove the hepatitis C virus in the patient body.
Manufacturing and Marketed by Natco Pharma Limited
Treatment genotype: Velpanat Velpatasvir is for the treatment of chronic hepatitis C genotype 1 to 6 infection. Velpanat is especially very useful for genotype 3 treatment.
2. HETERO HEALTHCARE LTD.
About Company: Hetero headquartered at Hyderabad. With a dedicated R&D and a vast range of pharmaceuticals products, the company aims to bring an improvement in the quality of life people. The company has a team committed to finding tomorrow’s cures and treatments for some of the most serious diseases that plague mankind. With over a century of experience, Hetero Healthcare brings to the table a comprehensive portfolio of products and a vertically aligned business model for the betterment of human life.
Generic Hep C medicines by Hetero Healthcare
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Sofovir Sofosbuvir 400 mg, Sofovir tablets contain Sofosbuvir 400mg salt. Sofovir Sofosbuvir efficacy has been established in subjects with HCV genotype 1, 2, 3 or 4 infections, including those with hepatocellular carcinoma meeting Milan criteria (awaiting liver transplantation) and those with HCV/HIV-1 co-infection.
Manufacturing and Marketed by Hetero Healthcare Ltd
Treatment genotype: HCV genotype 1, 2, 3 or 4
• Second Generation: (Sofosbuvir 400 mg + Ledipasvir 90 mg)
Generic Brand Name: Ledifos, is a fixed dose combination tablet containing Ledipasvir 90mg and Sofosbuvir 400mg. Ledipasvir is an HCV NS5A inhibitor and Sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase. Ledifos tablet is indicated with or without ribavirin for the treatment of patients with Chronic Hepatitis C virus (HCV) genotype 1, 4, 5 or 6 infection. The recommended dosage of Ledifos is one tablet, taken orally, once daily with or without food.
Manufacturing and Marketed by Hetero Healthcare
Treatment genotype: 1, 4, 5 or 6
• Third Generation: (Sofosbuvir 400 mg + Velpatasvir 100 mg)
Generic Brand Name: Velasof Sofosbuvir+Velpatasvir is a two-drug fixed dose combination product that contains 400mg of Sofosbuvir and 100mg of Velpatasvir in a single tablet. This fixed-dose combination is the generic version of Gilead’s brand Epclusa, approved by US FDA for the treatment of patients with chronic hepatitis C genotype 1 to 6.
Manufacturing and Marketed by Hetero Healthcare
Treatment genotype: Velasof is for the treatment of chronic hepatitis C genotype 1 to 6 infection.
3. ZYDUS CADILA HEALTHCARE LTD
About Company: Zydus Cadila is a united health care provider that offers complete healthcare solutions. Zydus products hold a prominent reputation in the domestic pharma industry sweepstakes.
Widely, the group has a strong presence in the regulated plenty markets such as US, Asia, Europe. Services offered in other countries have led to a strong presence in all those countries with emerging markets worldwide.
Generic Hep C medicines by Zydus Heptiza
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Sovihep Sofosbuvir 400 mg, The generic SoviHep has received approval in India in March 2015. SoviHep (Sofosbuvir) as a direct antiviral drug. It is for the people who affected by Hepatitis C HCV virus. SoviHep is used to cure chronic hepatitis C virus.
Manufactures by Natco Pharma, marketing and selling by Zydus Heptiza under their own brand name.
Treatment genotype: SoviHep treatment with different hep c genotype: It is suggested to take Sofosbuvir in a combination with other medications depending on the HCV genotype:
– HCV genotype 1 or 4 Patients should consume SoviHep (Sofosbuvir) with RBV and Peg IFN for 12 weeks.
– HCV genotype 1 or 4 Patients should consume SoviHep (Sofosbuvir) with RBV and Peg IFN for 12 weeks.
– HCV genotype 2 Patients should intake SoviHep (Sofosbuvir) with RBV for 12 weeks (without interferon)
– HCV genotype 3 Patients take SoviHep (sofosbuvir with RBV for 24 weeks (without interferon)- Interferon is injected under the skin, and ribavirin is taken by mouth.
• Second Generation: (Sofosbuvir 400 mg + Ledipasvir 90 mg)
Generic Brand Name: LediHep – The combination of Ledipasvir 90 mg and Sofosbuvir 400 mg provides an effective and well-tolerated fixed dose combination of a once-a pill once a day option for treatment of genotypes 1,4,5 and 6 chronic hepatitis C (HCV) infection. The direct-acting antiviral regimen was the first interferon – and ribavirin -free regimen that was approved FDA. The medicine can be used without ribavirin in most patients with genotype 1a with the exception of cirrhosis patients and treatment – experienced. Also, patients who are treatment-naive, without cirrhosis and not black are eligible for the 8-week duration which has been found to be as 12 weeks under observational studies.
Manufactures by Natco Pharma, marketing, and selling by Zydus Heptiza under their own brand name.
Treatment genotype: Ledihep is for the therapy of chronic hepatitis C genotype 1 to 4 infection.
• Third Generation: (Sofosbuvir 400 mg + Velpatasvir 100 mg)
Generic Brand Name: Sovihep V – medicine is a combo of Sofosbuvir 400 mg and Velpatasvir 100 mg. The drug works for completely removing hepatitis C virus in the patient body, helping your immune system fight the infection and may help the liver recover.
Manufactures by Natco Pharma, marketing, and selling by Zydus Heptiza under their own brand name.
Treatment genotype: Sovihep V is for the therapy of chronic hepatitis C genotype 1 to 6 infection. It treats all genotype 1 to 6. It is especially very useful for hep c genotype 3 treatment.
4. MYLAN LABORATORIES LTD.
About Company: Mylan Laboratories Ltd is one of the leading generic pharmaceutical companies in the world. Mylan manufactured and supply pharma products 165 countries and territories around the world. Mylan is the second-largest generic and specialty Pharmaceuticals Company in the world.
Generic Hep C medicines by Mylan Laboratories
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Myhep – It is Sofosbuvir 400 mg combination which is indicated for the treatment of Hepatitis C infection and provides a rationalized Hepatitis C treatment regimen that eliminates the need for interferon and ribavirin. These other generics are usually ribavirin (for all four genotypes) and pegylated interferon (for genotypes 1 and 4)
Manufactures by Natco Pharma, marketing and selling by Mylan Pharmaceuticals under their own brand name.
Treatment genotype: Genotypes 1, 2, 3, and 4 of Hepatitis C.
• Second Generation: (Sofosbuvir 400 mg + Ledipasvir 90 mg)
Generic Brand Name: Myhep LVIR– Sofosbuvir+Ledipasvir, the drug has signified safety and efficacy to cure certain types of HCV infection without the need for co-administration of interferon.
Manufactures by Natco Pharma, marketing and selling by Mylan Pharmaceuticals under their own brand name.
Treatment genotype: Treatment of chronic hepatitis C, genotypes 1, 2, 3, and 4
• Third Generation: (Sofosbuvir 400 mg + Velpatasvir 100 mg)
Generic Brand Name: Myhep All– The medicine is a combination of Sofosbuvir and Velpatasvir and can be used alone to treat chronic hepatitis C.
Manufactures by Natco Pharma, marketing, and selling by Mylan Pharmaceuticals under their own brand name.
Treatment genotype: Myhep All is for the treatment of chronic hepatitis C genotype 1 to 6 infection.
5. CIPLA LTD.
About Company: Cipla is a global pharmaceutical company which uses leading edge industrial science and variations to meet the everyday requirements of all patients. For more than 70 years, Cipla has been stated as one of the most venerated pharmaceutical names in India as well as across more than 150 countries. Cipla’s portfolio includes 1500 or more products in diverse medicinal service categories with one quality standard globally. Cipla has also offered significance on access for patients and was recognized globally for the pioneering role played in HIV/AIDS treatment. Cipla Ltd., a global pharmaceutical company which is treating patients since a long time. The company uses advanced technology and applied science to fulfill the everyday needs of all patients.
Generic Hep C medicines by Cipla
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Hepcvir (Sofosbuvir 400 mg) On 2015 Cipla Limited, a global pharmaceutical company announces the launch of generic medicine Sofosbuvir in India with the brand name ‘Hepcvir’. Following the non-exclusive licensing agreement signed with Gilead Sciences. Cipla is now all set to manufacture and market chronic hepatitis C medicines, the drug Sofosbuvir available for patients.
Manufactures by Hetero, marketing, and selling by Cipla Ltd under their own brand name.
• Second Generation: (Sofosbuvir 400 mg + Ledipasvir 90 mg)
Generic Brand Name: Hepcvir-L. In December 2015, the company announced the launch of generic drug Ledipasvir and Sofosbuvir in India under the brand name Hepcvir-L. Hepcvir-L was the first once-a-day, fixed-dose oral composite therapy that has been approved for chronic hepatitis C genotype 1 patients. The introduction of the Ledipasvir-Sofosbuvir fixed-dose oral combination thereby contribute a new interferon and ribavirin-free treatment option to patients and is a powerful anesthetic to fight against genotype 1 hepatitis C virus.
Manufactures by Hetero, marketing, and selling by Cipla Ltd under their own brand name.
Treatment genotype: Cipla Announces Launch of Hepcvir-L for Chronic Hepatitis C Genotype 1 Patients
• Third Generation: (Sofosbuvir 400 mg + Velpatasvir 100 mg)
Generic Brand Name: Hepcvel, Velpatasvir and Sofosbuvir Tablets
Manufactures by Hetero, marketing, and selling by Cipla Ltd under their own brand name.
Treatment genotype: Hepcvel is for the treatment of chronic hepatitis C genotype 1 to 6 infection.
6. RANBAXY LABORATORIES LTD
About Company: Ranbaxy Laboratories Ltd, an Indian Company offering treatments since 1961. The Japanese pharmaceutical company Daiichi Sankyo obtained a controlling share in 2008. The current corporation of Ranbaxy Laboratories Ltd, Daiichi Sankyo and Sun Pharma is 5th largest specialty generic pharma company across the globe. In 2013, Ranbaxy was exporting to 125 countries with the ground presence in 45 countries along with manufacturing plants in eight different countries.
Generic Hep C medicines by Ranbaxy
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Sofab (400mg) tablets help by lowering a load of hepatitis C virus in the body and discarding the virus from the blood over a period of time.
Manufactures by Hetero, marketing, and selling by Ranbaxy under their own brand name.
Treatment genotype: Sofosbuvir is used for the treatment of genotype 1, 2, 3 and 4 HCV
• Second Generation: (Sofosbuvir 400 mg + Ledipasvir 90 mg)
Generic Brand Name: Sofab LP, The medicine contains the compositions of Ledipasvir and Sofosbuvir.
Treatment genotype: Ribavirin for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6.
7. DR REDDY’S
About Company: Dr. Reddy’s Laboratories is an Indian MNC pharmaceutical company based in Hyderabad, India.Dr. Reddy’s manufactures and markets a wide range of pharmaceuticals in India and across the world.
Generic Hep C medicines by Dr. Reddy’s
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Resof Sofosbuvir 400 mg
• Second Generation: (Sofosbuvir 400 mg + Ledipasvir 90 mg)
Generic Brand Name: Resof-L
• Third Generation: (Sofosbuvir 400 mg + Velpatasvir 100 mg)
Generic Brand Name: Resof Total
8. ABBOTT INDIA LTD.
About Company: Abbott India Ltd. is a subsidiary of ABBOTT LABORATORIES. ABBOTT has been present in India for over a hundred years and is currently India’s largest healthcare product company, a position it gained after acquiring Piramal Healthcare Ltd’s healthcare solutions unit for $2.2 Billion.
Generic Hep C medicines by Abbott
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Resof Sofosbuvir 400 mg
• Second Generation: (Sofosbuvir 400 mg + Ledipasvir 90 mg)
Generic Brand Name: Ledviclear
Mfg. by Hetero Laboratories Limited and marketed by Abbott India Limited
9. BIOCON LTD.
Generic Hep C medicines by Biocon Ltd
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Cimivir Sofosbuvir 400 mg
• Second Generation: (Sofosbuvir 400 mg + Ledipasvir 90 mg)
Generic Brand Name: Cimivir-L
10. EMCURE PHARMA
Generic Hep C medicines by Emcure Pharma
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Sofocure
• Second Generation: (Sofosbuvir 400 mg + Ledipasvir 90 mg)
Generic Brand Name: Sofocure-L
11. STRIDES ARCOLAB
Generic Hep C medicines by Strides Arcolab
• First Generation: (Sofosbuvir 400 mg)
Generic Brand Name: Virso Sofosbuvir 400 mg